Product information
From Health Canada
Current status:
Marketed
Current status date:
2018-04-20
Original market date: See footnote 1
1986-12-31
Product name:
TEVA-PREDNISOLONE
DIN:
00700401 Electronic product monograph is not available
Company:
TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01BA04 PREDNISOLONE
Active ingredient group (AIG) number:See footnote5
0106295001
Active ingredient(s) | Strength |
---|---|
PREDNISOLONE ACETATE | 1 % |